Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.

Karagianis JL, Phillips LC, Hogan KP, LeDrew KK.

Ann Pharmacother. 1999 May;33(5):623-30. Review.

PMID:
10369628
2.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
3.

Neuroleptic malignant syndrome and clozapine.

Reddig S, Minnema AM, Tandon R.

Ann Clin Psychiatry. 1993 Mar;5(1):25-7.

PMID:
8102300
4.

Neuroleptic malignant syndrome associated with clozapine treatment.

Tsai G, Crisostomo G, Rosenblatt ML, Stern TA.

Ann Clin Psychiatry. 1995 Jun;7(2):91-5.

PMID:
8556099
5.

Suspected neuroleptic malignant syndrome in a patient receiving clozapine.

Ganelin L, Lichtenberg PS, Marcus EL, Munter RG.

Ann Pharmacother. 1996 Mar;30(3):248-50.

PMID:
8833560
6.

Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.

Sachdev P, Kruk J, Kneebone M, Kissane D.

J Clin Psychopharmacol. 1995 Oct;15(5):365-71. Review.

PMID:
8830069
7.

[Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].

Erol A, Putgül G, Sert E, Mete L.

Turk Psikiyatri Derg. 2013 Summer;24(2):140-4. Turkish.

8.

Atypical neuroleptic malignant syndrome with long-term clozapine.

Corallo CE, Ernest D.

Crit Care Resusc. 2007 Dec;9(4):338-40.

PMID:
18052897
9.

Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.

Croarkin PE, Emslie GJ, Mayes TL.

J Clin Psychiatry. 2008 Jul;69(7):1157-65. Review.

PMID:
18572981
10.

Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.

Tseng PT, Chang YC, Chang CH, Wang HY, Cheng YS, Wu CK, Chen YW, Chung W.

Int J Psychiatry Med. 2015;49(1):35-43. doi: 10.2190/PM.49.1.c. Review.

PMID:
25838319
11.

Olanzapine induced neuroleptic malignant syndrome--a case review.

Kogoj A, Velikonja I.

Hum Psychopharmacol. 2003 Jun;18(4):301-9. Review.

PMID:
12766935
12.

Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.

Hasan S, Buckley P.

Am J Psychiatry. 1998 Aug;155(8):1113-6. Review.

PMID:
9699705
13.

Rechallenging clozapine after neuroleptic malignant syndrome.

Anbalagan E, Ithman M, Lauriello J.

Psychiatr Q. 2014 Sep;85(3):345-8. doi: 10.1007/s11126-014-9291-9.

PMID:
24633526
14.

A case of clozapine-induced neuroleptic malignant syndrome.

Miller DD, Sharafuddin MJ, Kathol RG.

J Clin Psychiatry. 1991 Mar;52(3):99-101.

PMID:
1672311
15.

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.

World J Biol Psychiatry. 2009;10(1):70-3. doi: 10.1080/15622970701287369.

PMID:
19673089
17.

Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.

Bottlender R, Jäger M, Hofschuster E, Dobmeier P, Möller HJ.

Pharmacopsychiatry. 2002 May;35(3):119-21.

PMID:
12107858
18.

Neuroleptic malignant syndrome due to olanzapine.

Hall KL, Taylor WH, Ware MR.

Psychopharmacol Bull. 2001 Summer;35(3):49-54.

PMID:
12397878
19.

Neuroleptic malignant syndrome induced by atypical antipsychotics.

Farver DK.

Expert Opin Drug Saf. 2003 Jan;2(1):21-35. Review.

PMID:
12904122
20.

Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

Belvederi Murri M, Guaglianone A, Bugliani M, Calcagno P, Respino M, Serafini G, Innamorati M, Pompili M, Amore M.

Drugs R D. 2015 Mar;15(1):45-62. doi: 10.1007/s40268-014-0078-0. Review.

Supplemental Content

Support Center